Nectar Lifesciences Limited has announced the closure of its trading window for designated persons and their immediate relatives. This closure will be effective from January 01, 2026. The trading window will remain shut until 48 hours after the declaration of the financial results for the quarter ended December 31, 2025. Designated persons and their immediate relatives are hereby advised not to engage in any trading of the company's securities during this specified period. This notice is issued in accordance with the Code of Conduct under Regulation 9 of SEBI (Prohibition of Insider Trading) Regulations, 2015, and is considered a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.